<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Urology</title>
            <link>https://medicalxpress.com/urology-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Urology</description>

                            <item>
                    <title>Low-risk prostate tumors reveal molecular signs linked to more aggressive cancer</title>
                    <description>A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been classified as low risk, highlighting biological differences that may not be apparent from clinical measures alone. The results could lead to new therapeutic strategies.</description>
                    <link>https://medicalxpress.com/news/2026-10-prostate-tumors-reveal-molecular-linked.html</link>
                    <category></category>
                    <pubDate>Wed, 07 Oct 2026 16:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news710605686</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/low-risk-prostate-tumo.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance</title>
                    <description>Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.</description>
                    <link>https://medicalxpress.com/news/2026-10-key-driver-aggressive-prostate-cancer.html</link>
                    <category></category>
                    <pubDate>Wed, 07 Oct 2026 11:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news710522401</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/key-driver-of-aggressi.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>RNA urine test outperforms standard bladder cancer tests and could help guide treatment</title>
                    <description>A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose bladder cancer more accurately than current standard methods. The test also allows physicians not only to assess the cancer&#039;s response to treatment but also to predict whether immunotherapy or chemotherapy is likely to be most effective for each patient.</description>
                    <link>https://medicalxpress.com/news/2026-10-rna-urine-outperforms-standard-bladder.html</link>
                    <category></category>
                    <pubDate>Fri, 02 Oct 2026 05:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news710067602</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/urine-test-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Combination therapy emerges as possible treatment for an aggressive form of kidney cancer</title>
                    <description>A genetic vulnerability in clear cell renal cell carcinoma, the most aggressive type of kidney cancer, may lend itself to a combination treatment strategy that causes the cancer cells to self-destruct, according to recent research published in the Proceedings of the National Academy of Sciences.</description>
                    <link>https://medicalxpress.com/news/2026-09-combination-therapy-emerges-treatment-aggressive.html</link>
                    <category></category>
                    <pubDate>Wed, 30 Sep 2026 17:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news710000703</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/combination-therapy-em.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Hidden E. coli survive in bladder cells, but existing drug helps antibiotics reach them in lab tests</title>
                    <description>Urinary tract infections, or UTIs, are among the most common bacterial infections and are caused mostly by the uropathogenic bacterium Escherichia coli. But even after antibiotic treatment, many patients experience another UTI.</description>
                    <link>https://medicalxpress.com/news/2026-09-hidden-coli-survive-bladder-cells.html</link>
                    <category></category>
                    <pubDate>Fri, 25 Sep 2026 14:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news709545120</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/helping-bladder-cells.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Neurotransmitter may help aggressive prostate cancer shut out immune cells from the start</title>
                    <description>A new study from The Wistar Institute has found a link between the nervous system and the rapid development of neuroendocrine prostate cancer (NEPC), an aggressive form of the disease. Published in Oncogene, the study found high levels of neuromedin U (NMU), a neurotransmitter, in prostate cells during the earliest phase of NEPC formation.</description>
                    <link>https://medicalxpress.com/news/2026-09-neurotransmitter-aggressive-prostate-cancer-immune.html</link>
                    <category></category>
                    <pubDate>Fri, 25 Sep 2026 11:40:23 EDT</pubDate>
                    <guid isPermaLink="false">news709553101</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/scientists-identify-co.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Exercise may ease stress-related bladder pain and frequent urination</title>
                    <description>Chronic stress may contribute to the pain and urinary symptoms experienced by people with interstitial cystitis/bladder pain syndrome (IC/BPS) by triggering changes in the bladder and nervous system, according to a preclinical study by Weill Cornell Medicine investigators.</description>
                    <link>https://medicalxpress.com/news/2026-09-ease-stress-bladder-pain-frequent.html</link>
                    <category></category>
                    <pubDate>Wed, 23 Sep 2026 09:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news709373401</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/bladder.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Use of MRI before prostate biopsies increases sharply across U.S. hospitals</title>
                    <description>Using prostate MRI before a biopsy is a real advance in prostate cancer diagnosis. Multiple randomized trials have shown that imaging the prostate first and then targeting suspicious lesions finds more of the aggressive cancers that matter. As a result, guidelines have progressively strengthened their recommendations for MRI.</description>
                    <link>https://medicalxpress.com/news/2026-09-mri-prostate-biopsies-sharply-hospitals.html</link>
                    <category></category>
                    <pubDate>Sun, 20 Sep 2026 15:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news708960663</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/mri.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Prostate cancer: Specialized imaging could prevent unnecessary biopsies</title>
                    <description>An elevated PSA level in the blood may indicate prostate cancer but does not allow for a definitive diagnosis. Where there is a corresponding suspicion, a tissue sample is usually taken from the prostate. A study by the Medical University of Vienna now shows that a specialized form of imaging—known as PSMA-PET/CT—could provide important additional information even before such a biopsy is carried out.</description>
                    <link>https://medicalxpress.com/news/2026-09-prostate-cancer-specialized-imaging-unnecessary.html</link>
                    <category></category>
                    <pubDate>Tue, 15 Sep 2026 17:40:07 EDT</pubDate>
                    <guid isPermaLink="false">news708704822</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/prostate-cancer-specia.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Combination therapy may improve immune response against advanced prostate cancer</title>
                    <description>Combining the targeted therapy olaparib with an additional immunotherapy may improve immune response in a subgroup of patients with metastatic castration-resistant prostate cancer who responded poorly to initial treatment, according to a Northwestern Medicine study published in The Journal of Clinical Investigation.</description>
                    <link>https://medicalxpress.com/news/2026-09-combination-therapy-immune-response-advanced.html</link>
                    <category></category>
                    <pubDate>Thu, 10 Sep 2026 15:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news708262756</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/combination-therapy-ma.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Certain DNA signatures may reveal which prostate cancers are most likely to spread</title>
                    <description>Prostate cancer is the second most common form of cancer among men globally. Yet, we still know relatively little about why the disease develops or why some men live with it for years while it progresses aggressively in others.</description>
                    <link>https://medicalxpress.com/news/2026-09-dna-signatures-reveal-prostate-cancers.html</link>
                    <category></category>
                    <pubDate>Wed, 09 Sep 2026 11:00:20 EDT</pubDate>
                    <guid isPermaLink="false">news708169081</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/prostate-cancer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Bacteria that can make testosterone: What could that mean for prostate cancer?</title>
                    <description>Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease often try to reduce testosterone production or block its effects. Now, scientists have identified an unexpected participant in androgen chemistry: a bacterium from the human urinary tract that can convert the steroid precursor DHEA into testosterone under laboratory conditions.</description>
                    <link>https://medicalxpress.com/news/2026-09-bacteria-testosterone-prostate-cancer.html</link>
                    <category></category>
                    <pubDate>Mon, 07 Sep 2026 09:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news707989741</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/bacteria-can-make-test.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Micro-bladder model offers clues to stopping recurrent UTIs</title>
                    <description>A lab-grown micro bladder may explain why urinary tract infections (UTIs) return so frequently, according to a study led by researchers at UCL, the University of Oxford and the University of Leicester.</description>
                    <link>https://medicalxpress.com/news/2026-09-micro-bladder-clues-recurrent-utis.html</link>
                    <category></category>
                    <pubDate>Fri, 04 Sep 2026 05:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news707653211</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/micro-bladder-model-of.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
